source
- FDA grants accelerated approval to sonrotoclax for relapsed/refractory mantle cell lymphomaThe U.S. Food and Drug Administration has granted accelerated approval to sonrotoclax (brand name Beqalzi) for adult patients with relapsed or refractory mantle cell lymphoma who have received at l…
- FDA leadership gap deepens uncertainty for biotech as acting officials take chargeMarty Makary's resignation as FDA commissioner has left the agency without a permanent head. Kyle Diamantas is serving as the temporary leader, while three senior drug-review positions are filled b…